申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US04010184A1
公开(公告)日:1977-03-01
Thienodiazepines of the formula: ##STR1## wherein Ar is mono- or di-substituted phenyl [the substituents(s) being H, halogen, C.sub.1.sub.-4 alkyl or C.sub.1.sub.-4 alkoxy] or pyridyl; R.sup.1 is H or C.sub.1.sub.-4 alkyl; R.sup.2 is H, halogen or C.sub.1.sub.-4 alkyl; or R.sup.1 and R.sup.2 combinedly form -(CH.sub.2).sub.4 -; each of R.sup.3 and R.sup.4 is C.sub.1.sub.-4 alkyl, or R.sup.3 and R.sup.4 together with the adjacent nitrogen atom form a heterocyclic group; A is C.sub.2.sub.-4 alkylene; and n is an integer of zero and 1; and pharmaceutically acceptable acid addition salts thereof are disclosed. They are useful as analgesics.
公式为Thienodiazepines:其中Ar是单取代或双取代苯基[取代基为H、卤素、C.sub.1.sub.-4烷基或C.sub.1.sub.-4烷氧基]或吡啶基;R.sup.1为H或C.sub.1.sub.-4烷基;R.sup.2为H、卤素或C.sub.1.sub.-4烷基;或R.sup.1和R.sup.2合并形成-(CH.sub.2).sub.4-;R.sup.3和R.sup.4中的每一个为C.sub.1.sub.-4烷基,或R.sup.3和R.sup.4与相邻的氮原子形成杂环基团;A为C.sub.2.sub.-4烷基;n为0和1之间的整数;以及其药用可接受的酸盐。它们可用作镇痛药。